Helius Medical Technologies, Inc. (HSDT)
NASDAQ: HSDT · Real-Time Price · USD
6.09
-0.03 (-0.49%)
At close: Sep 2, 2025, 4:00 PM
6.09
0.00 (0.00%)
After-hours: Sep 2, 2025, 6:48 PM EDT
HSDT Employees
Helius Medical Technologies had 21 employees as of December 31, 2024. The number of employees decreased by 1 or -4.55% compared to the previous year.
Employees
21
Change (1Y)
-1
Growth (1Y)
-4.55%
Revenue / Employee
$14,048
Profits / Employee
-$1,013,571
Market Cap
6.56M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 21 | -1 | -4.55% |
| Dec 31, 2023 | 22 | -4 | -15.38% |
| Dec 31, 2022 | 26 | 7 | 36.84% |
| Dec 31, 2021 | 19 | 0 | - |
| Dec 31, 2020 | 19 | 0 | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
HSDT News
- 6 weeks ago - Helius Announces Positive Outcome of the Portable Neuromodulation Stimulator PoNS® Stroke Registrational Program and Upcoming Submission to FDA Under Breakthrough Designation - GlobeNewsWire
- 7 weeks ago - Helius Medical Technologies, Inc. Compliant with Nasdaq's Continued Listing Requirements - GlobeNewsWire
- 2 months ago - Helius Medical Technologies, Sunrun And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Benzinga
- 2 months ago - Helius Medical Technologies Announces Reverse Stock Split - GlobeNewsWire
- 2 months ago - Helius Medical Technologies, Inc. Announces Claim Authorization by CignaHealth, for its Portable Neuromodulation Stimulator (PoNS®) Device - GlobeNewsWire
- 2 months ago - Positive PoNSTEP Study Results Presented at Consortium of Multiple Sclerosis Centers Annual Meeting - GlobeNewsWire
- 2 months ago - Helius Medical Technologies, Inc. Announces Authorized Claim for Payment by Major Healthcare Payer for its Portable Neuromodulation Stimulator (PoNS®) Device - GlobeNewsWire
- 3 months ago - Helius Medical Technologies Announces Pricing of $9.1 Million Public Offering - GlobeNewsWire